Dentsply Sirona Launches FDA-Cleared AI Tool to Boost Periapical Radiolucency Detection

Event summary

  • Dentsply Sirona launched Smart View - Detect, the first FDA-cleared AI tool for detecting periapical radiolucencies (PARLs) in CBCT scans.
  • The tool achieved a 46% relative increase in PARL detection sensitivity in clinical studies.
  • Smart View - Detect is available through DS Core and compatible with existing Dentsply Sirona CBCT systems.
  • The feature will be available starting May 12, 2026, in the U.S. and Europe.

The big picture

Dentsply Sirona's launch of Smart View - Detect underscores the growing role of AI in dental diagnostics, addressing the challenge of efficiently reviewing complex CBCT data. The tool's FDA clearance and immediate availability through DS Core position it as a potential industry standard, particularly as periapical radiolucencies affect over half of adults. The strategic move aligns with broader trends in connected dentistry, where cloud-based platforms are becoming central to clinical decision-making.

What we're watching

Adoption Pace
The pace at which dental practices integrate Smart View - Detect into existing workflows.
Competitive Response
Whether competitors will accelerate their own AI diagnostic tool development.
Regulatory Expansion
How quickly the tool gains approval in other major markets beyond the U.S. and Europe.

Related topics

Product Launch